MedTrace Logo

EMDR vs. CBT for PTSD

NCT06758362 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2025-06-19

No results posted yet for this study

Summary

This study compares two evidence-based therapies, Eye Movement Desensitization and Reprocessing (EMDR) and Cognitive Behavioral Therapy (CBT), in reducing symptoms of post-traumatic stress disorder (PTSD) among adults affected by the 2023 Kahramanmaraş earthquakes in Türkiye. A total of 89 participants diagnosed with PTSD were randomly assigned to one of three groups: EMDR therapy, CBT therapy, or a no-treatment control group. Each participant in the treatment groups received 12 weekly, one-on-one, 50-minute therapy sessions delivered remotely via a secure online platform. PTSD and related symptoms (depression, anxiety, and emotion dysregulation) were assessed at three time points: before therapy (T1), after the 6th session (T2), and after the 12th session (T3). This study aims to evaluate which therapy yields stronger improvements in PTSD and related psychological outcomes when delivered remotely in a disaster-affected population.

Conditions

  • Post Traumatic Stress Disorder PTSD

Interventions

BEHAVIORAL

Eye Movement Desensitization and Reprocessing (EMDR)

A structured psychotherapy approach focused on reducing PTSD symptoms through guided eye movements and trauma processing.

BEHAVIORAL

Cognitive Behavioral Therapy (CBT)

A psychotherapy approach focused on identifying and modifying maladaptive thought patterns and behaviors to reduce PTSD symptoms.

Sponsors & Collaborators

  • Uskudar University

    collaborator OTHER

  • Beykoz University

    collaborator OTHER

  • Istanbul Nisantasi University

    lead OTHER

Principal Investigators

  • Gökben Hızlı Sayar, Prof · Üsküdar University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2025-03-28
Completion
2025-07-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06758362 on ClinicalTrials.gov